EUVIMEDEUVIMED entdecken
CrossrefInfokarte

4‐Octyl Itaconate Restores Microglial Efferocytosis by Suppressing NRF2 / PD ‐ L1 ‐Dependent Neutrophil NET Formation in Sepsis‐Associated Encephalopathy

Na Meng, Xixue Zhang, Kaiwen Tian, Yue Zhou, Lei Gao, Fafa Sun, Yulin Zhang, Lina Huang, Weidong Gu

CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)

DOI: 10.1002/cns.71268 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Sepsis‐associated encephalopathy (SAE) is a frequent neurological complication of sepsis characterized by acute neurobehavioral abnormalities and persistent cognitive impairment. Although 4‐octyl itaconate (4‐OI) possesses potent immunomodulatory properties, its neuroprotective effects and underlying mechanisms in SAE remain unclear. Methods Sepsis was induced by cecal ligation and puncture (CLP), and mice were treated with 4‐OI. Behavioral tests were used to assess anxiety‐like behavior and cognitive function. Transcriptomic and single‐cell RNA‐seq analyses were performed to characterize efferocytosis‐related changes in the septic hippocampus. Western blot, immunofluorescence, flow cytometry, experiments using primary neutrophils and microglia, pharmacological interventions, and Padi4 −/− mice were used to investigate NET formation and microglial efferocytosis. Results 4‐OI improved neurobehavioral and cognitive outcomes, reduced hippocampal injury, blood–brain barrier disruption, and neuroinflammation, and suppressed NET accumulation in the septic hippocampus and LPS‐stimulated neutrophils. NRF2 inhibition weakened the effects of 4‐OI on neutrophil PD‐L1 expression and NET formation, whereas PD‐L1 neutralization reduced NET formation. Transcriptomic analyses identified microglia/myeloid‐associated efferocytosis programs. NETs impaired microglial efferocytosis, while DNase I treatment or PAD4 deficiency preserved apoptotic cell clearance. Conclusions 4‐OI protects against septic brain injury and cognitive dysfunction by activating NRF2, suppressing PD‐L1‐mediated NET formation, and mitigating NET‐associated impairment of microglial efferocytosis.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →